Connection

Brian Booth to Cell Line, Tumor

This is a "connection" page, showing publications Brian Booth has written about Cell Line, Tumor.
Connection Strength

0.721
  1. The in vivo biocompatibility of novel tannic acid-collagen type I injectable bead scaffold material for breast reconstruction post-lumpectomy. J Biomater Appl. 2020 04; 34(9):1315-1329.
    View in: PubMed
    Score: 0.121
  2. Amphiregulin regulates proliferation and migration of HER2-positive breast cancer cells. Cell Oncol (Dordr). 2018 Apr; 41(2):159-168.
    View in: PubMed
    Score: 0.105
  3. HER2+ breast cancer cells undergo apoptosis upon exposure to tannic acid released from remodeled cross-linked collagen type I. J Biomed Mater Res A. 2018 Jan; 106(1):26-32.
    View in: PubMed
    Score: 0.104
  4. Cancer cell redirection biomarker discovery using a mutual information approach. PLoS One. 2017; 12(6):e0179265.
    View in: PubMed
    Score: 0.101
  5. RNA Expression Profiling Reveals Differentially Regulated Growth Factor and Receptor Expression in Redirected Cancer Cells. Stem Cells Dev. 2017 05 01; 26(9):646-655.
    View in: PubMed
    Score: 0.099
  6. Validation of an in vitro model of erbB2(+) cancer cell redirection. In Vitro Cell Dev Biol Anim. 2015 Sep; 51(8):776-86.
    View in: PubMed
    Score: 0.088
  7. Remodeling of tannic acid crosslinked collagen type I induces apoptosis in ER+ breast cancer cells. Anticancer Res. 2015 Mar; 35(3):1285-90.
    View in: PubMed
    Score: 0.087
  8. Reprogramming human cancer cells in the mouse mammary gland. Cancer Res. 2010 Aug 01; 70(15):6336-43.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.